TPG Pace Holdings Sets Extension Vote Date
by Kristi Marvin on 2019-09-05 at 6:31pm

TPG filed both the proxy for their Extension Vote, as well as the S-4/proxy for their Business combination.

TPG Pace Holdings (TPGH), filed their definitive proxy tonight and set a September 20th vote date to extend their completion deadline three months to December 31, 2019.  Additionally, in a surprise move, TPGH also filed their S-4/preliminary proxy for their business combination vote (the extension definitive proxy and S-4 are for two separate votes), which could be indicative of a much earlier close than December.

However, the real headline here is that TPGH is not offering any contribution to trust for shareholders that do not redeem at the extension vote.  Always a little risky since that generally results in a lot of redemptions.  TPGH is currently trading at $10.30 and they estimate the per share amount in trust at the vote on September 20th will be $10.29, so it’s trading right around trust value.   So now, shareholders are going to have to decide if they want to stay in this SPAC for an additional three months without an additional sweetener and see what happens with the share price or, they can just redeem now and collect their $10.29.

Having said that, there are a few other considerations that need to be accounted for.  For one, maybe shareholders won’t have to wait the full three months.  As mentioned above, TPGH also filed their first S-4 proxy tonight for the business combination vote so that could mean we see this vote happen as early as late October.  However, take that with a grain of salt…it could also be a strategic marketing move hoping that the “signal” of a shorter duration to wait for a vote entices people not to redeem.  But let’s give them the benefit of the doubt that they want to close this transaction as quickly as we do.

Nevertheless, TPGH has two other pieces of recent news that need to be factored into the equation. One, Clairvest (Accel’s minority shareholder) dropped their lawsuit clearing the way for a transaction closing.  And two, Accel recently announced the $108 million acquisition of Grand River Jackpot increasing the total Accel acquisition enterprise value to $984 million. All of this is to say, a lot can happen in three months.  Just ask the Haymaker guys.  Once the Haymaker team hit the road to market the OSW transaction, that’s when the share price really started to move.  And TPGH still hasn’t marketed this deal yet.

This is going to be a tough vote to call, but even if there are more redemptions than TPGH would like, something tells me they’ll have no problem arranging additional financing if they need it.  If any further information is filed, an update will be provided. Stay tuned….

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved